MX354316B - Pharmaceutical composition with an antihypertensive and diuretic. - Google Patents
Pharmaceutical composition with an antihypertensive and diuretic.Info
- Publication number
- MX354316B MX354316B MX2012011902A MX2012011902A MX354316B MX 354316 B MX354316 B MX 354316B MX 2012011902 A MX2012011902 A MX 2012011902A MX 2012011902 A MX2012011902 A MX 2012011902A MX 354316 B MX354316 B MX 354316B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutically acceptable
- liquid
- agents
- pharmaceutical composition
- diuretic
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention refers to a novel pharmaceutical composition in water-free liquid forms contained in a hard gelatin capsule and/or soft gelatin capsule, which consists in a) a pharmaceutically acceptable amount of one or more antihypertensive agents of angiotensin II receptor antagonist in combination with, b) a pharmaceutically acceptable amount of one or more diuretic agents, c) at least an agent for increasing the solubility of the active principles, d) at least an alkaline agent, e) at least an antioxidant and/or preserver, f) at least a pharmaceutically acceptable vehicle and/or at least a pharmaceutically acceptable excipient; all agents are contained in an oral administration system which contains one or more phases that are not limited to: liquid-liquid, liquid-solid, which is used for the treatment and/or control of hypertension and/or associated disorders.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012011902A MX354316B (en) | 2012-10-12 | 2012-10-12 | Pharmaceutical composition with an antihypertensive and diuretic. |
PE2013002275A PE20141320A1 (en) | 2012-10-12 | 2013-10-11 | PHARMACEUTICAL COMPOSITION WITH AN ANTIHYPERTENSIVE AND A DIURETIC |
BR102013026288-9A BR102013026288B1 (en) | 2012-10-12 | 2013-10-11 | PHARMACEUTICAL COMPOSITION WITH AN ANTIHYPERTENSIVE AND DIURETIC |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012011902A MX354316B (en) | 2012-10-12 | 2012-10-12 | Pharmaceutical composition with an antihypertensive and diuretic. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012011902A MX2012011902A (en) | 2014-04-28 |
MX354316B true MX354316B (en) | 2018-02-26 |
Family
ID=51213229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011902A MX354316B (en) | 2012-10-12 | 2012-10-12 | Pharmaceutical composition with an antihypertensive and diuretic. |
Country Status (3)
Country | Link |
---|---|
BR (1) | BR102013026288B1 (en) |
MX (1) | MX354316B (en) |
PE (1) | PE20141320A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11878022B2 (en) | 2020-12-10 | 2024-01-23 | Novitium Pharma LLC | Hydrochlorothiazide compositions |
-
2012
- 2012-10-12 MX MX2012011902A patent/MX354316B/en active IP Right Grant
-
2013
- 2013-10-11 PE PE2013002275A patent/PE20141320A1/en not_active Application Discontinuation
- 2013-10-11 BR BR102013026288-9A patent/BR102013026288B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11878022B2 (en) | 2020-12-10 | 2024-01-23 | Novitium Pharma LLC | Hydrochlorothiazide compositions |
Also Published As
Publication number | Publication date |
---|---|
BR102013026288A2 (en) | 2015-08-04 |
BR102013026288B1 (en) | 2020-08-04 |
MX2012011902A (en) | 2014-04-28 |
PE20141320A1 (en) | 2014-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016006053A (en) | Selective pyy compounds and uses thereof. | |
MX2017004592A (en) | Pharmaceutical formulations for the oral delivery of peptide or protein drugs. | |
PH12015501595A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
PE20181523A1 (en) | TREATMENT OF LUPUS NEFRITIS USING LAQUINIMOD | |
PH12015501598A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MX2017015105A (en) | Selective pyy compounds and uses thereof. | |
PH12015501600A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MY188450A (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
MY160728A (en) | Morpholinothiazoles as alpha 7 positive allosteric modulators | |
CO2017012670A2 (en) | Orodispersible dosing unit containing an estetrol component | |
MA34083B1 (en) | PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS | |
GT201700270A (en) | ORODISPERSABLE DOSING UNIT CONTAINING A STETROL COMPONENT | |
MY160652A (en) | Pharmaceutical composition for oral administration | |
EA201990249A1 (en) | APPLICATION AND DOSAGE MODE OF THERAPEUTIC AGENTS IN ENDOMETRIOSIS | |
MX2013001637A (en) | Oral controlled release pharmaceutical compositions of blonanserin. | |
EA201590474A1 (en) | PHARMACEUTICAL COMPOSITION BASED ON COMPOSITE CAPSULES INCLUDING IRBESARTAN AND HMG-COA REDUCTASE INHIBITOR | |
MX2012011902A (en) | Pharmaceutical composition with an antihypertensive and diuretic. | |
MX2018013969A (en) | Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist. | |
NZ764004A (en) | Heteroaryl compounds as muscarinic m1 receptor positive allosteric modulators | |
MX356245B (en) | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimet hyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid. | |
WO2020013776A3 (en) | Synergistic effect of naproxen and a gastro protective agent for the treatment of pain and inflammation | |
MX345469B (en) | Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent. | |
EA201590732A1 (en) | DISPENSABLE TABLET | |
TR201008460A1 (en) | Sachet formulations of eslicarbazepine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |